Articles for Clinical

The drug is now indicated for adult and pediatric patients with unresectable or metastatic microsatellite instability-high or mismatch repair deficient solid tumors that lack suitable alternative treatments or that have progressed on treatment.
A study published in the Annals of Internal Medicine reports that black Medicare enrollees are less likely to receive colonoscopy from more highly-rated physicians, which could increase their risk for interval colorectal cancer.
Comprehensive genetic testing using multigene testing panels for prostate cancer can arm genetic counselors with the information they need to guide precision therapy, even in men with early stage disease but a strong family history of the disease.
Zachary Bloomgarden, MD; Robert Gabbay, MD, PhD, FACP; Silvio Inzucchi, MD; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, remark on forthcoming results of cardiovascular outcomes trials and discuss payer considerations for the newer treatment indications entering the market.
An analysis of discontinuation in randomized controlled trials for chronic obstructive pulmonary disease (COPD) has determined the main factors causing patients to drop out of clinical trials. The results were published in the International Journal of COPD.
Panelists Peter L. Salgo, MD; Charles Wykoff, MD, PhD; Jared Nielsen, MD; and Peter Dehnel, MD, explain the stages of progression with age-related macular degeneration and the differences between the wet and dry forms.
Panelists Peter L. Salgo, MD; Jared Nielsen, MD; Charles Wykoff, MD, PhD; and Gary L. Johnson, MD, MS, MBA, define age-related macular degeneration and provide insight regarding its impact on patients and caregivers.
John Fox, MD, MHA, provides insight regarding second-line options in advanced non–small cell lung cancer.
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium